Adjuvant Chemotherapy May Not Be Necessary for Women with Stage IC1 Epithelial Ovarian Cancer

作     者：Dong-mei DENG Qiu-yue LIAO Jie YANG Jing CHEN Ge CHEN Hua-lin BAI Bo ZHANG Ke-zhen LI Dong-mei DENG;Qiu-yue LIAO;Jie YANG;Jing CHEN;Ge CHEN;Hua-lin BAI;Bo ZHANG;Ke-zhen LI

作者机构：Department of Gynecology and ObstetricsTongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030China 

出 版 物：《Current Medical Science》 (当代医学科学（英文）)

年 卷 期：2022年第42卷第1期

页      面：192-200页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：This study was supported by grants from the National Key Technology R&D Program of China(No.2019YFC1005200 No.2019YFC1005202 and2018YFC1002103) 

主　　题：adjuvant chemotherapy epithelial ovarian cancer intraoperative rupture overall survival progression-free survival 

摘      要：Objective:To determine whether adjuvant chemotherapy improves the prognoses in women with stage IC1 epithelial ovarian cancer(EOC).Methods:All eligible women diagnosed with stage IC1 EOC from 2003 to 2019 in Tongji Hospital were *** characteristics,tumor features,surgical types,and chemotherapeutic treatments were ***-Meier analysis and Cox regression analysis were performed to evaluate progression-free survival(PFS)and overall survival(OS).